Anti-arthritic and anti-inflammatory effects of BMZD-2CPE in a CFA and carrageenan-induced animal model
- 30 September 2025
- journal article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (3) , 3495-3508
Abstract
The goal of the study was to evaluate the anti-inflammatory and immunomodulatory effects of benzimidazole derivative-2-((1H-benzo[d] imidazole-2-yl)thio)-1-(3-(3-chlorophenyl)-5-phenyl-1 H-pyrazol-1-yl) ethanone (BMZD-2CPE) in CFA-induced arthritic rat model. The doses of the BMZD-2CPE (benzimidazole derivative) used were 25, 50, and 75 mg/kg, respectively. Treatment with BMZD-2CPE and piroxicam was started on the 7th day of arthritic induction and continued for 20 days. All animals were sacrificed on the 27th day. A digital water plethysmometer was used to measure paw edema. An arthritic scoring index was used to determine the presence of arthritis. Biochemical parameters and blood analysis were determined. q-PCR was used to assess the mRNA expression of pro-inflammatory cytokines such as TNF-α and IL-6. PGE2 levels were determined using ELISA. The anti-inflammatory properties of BMZD-2CPE were evaluated using an acute inflammatory carrageenan-induced paw edema model. BMZD-2CPE reduced paw edema and slowed the progression of arthritic disease. After receiving BMZD-2CPE treatment, all histopathological parameters were seen to be considerably decreased. mRNA expression levels of pro-inflammatory cytokines such as TNF-α and IL-6 were markedly decreased in treatment groups. BMZD-2CPE also downregulated PGE2 levels in treatment groups. All results were comparable to piroxicam. Hemoglobin (Hb) and red blood cell (RBC) levels were restored in the treated groups. Furthermore, the levels of white blood cells and platelets in the treated groups were significantly reduced. Creatinine, urea, alanine transaminase, and aspartate aminotransferase levels were found to be non-significantly different indicating safety of the compound. BMZD-2CPE in various doses (more potentially in higher dose) showed anti-inflammatory and immunomodulatory properties.Keywords
This publication has 38 references indexed in Scilit:
- Long-term side effects of glucocorticoidsExpert Opinion on Drug Safety, 2016
- NSAID-induced Gastrointestinal InjuryJournal of Clinical Gastroenterology, 2016
- Protective effect of apigenin on Freund’s complete adjuvant-induced arthritis in rats via inhibiting P2X7/NF-κB pathwayChemico-Biological Interactions, 2015
- Association between mean platelet volume levels and inflammation in SLE patients presented with arthritisAfrican Health Sciences, 2015
- Anti-arthritic activity of N′-[(2,4-dihydroxyphenyl)methylidene]-2-(3,4-dimethyl-5,5-dioxidopyrazolo[4,3-c][1,2]benzothiazin-1(4H)-yl)acetohydrazideEuropean Journal of Pharmacology, 2014
- Anti-Arthritic Effects of Magnolol in Human Interleukin 1β-Stimulated Fibroblast-Like Synoviocytes and in a Rat Arthritis ModelPLOS ONE, 2012
- Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumabAnnals of the Rheumatic Diseases, 2007
- Wound healing: an overview of acute, fibrotic and delayed healingFrontiers in Bioscience-Landmark, 2004
- The role of COX-2 in angiogenesis and rheumatoid arthritis☆Experimental and Molecular Pathology, 2003
- The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritisArthritis & Rheumatism, 2000